Analyst EPS estimates for LENZ Therapeutics Inc. (LENZ) stock

After finishing at $21.81 in the prior trading day, LENZ Therapeutics Inc. (NASDAQ: LENZ) closed at $22.33, up 2.38%. In other words, the price has increased by $+0.52 from its previous closing price. On the day, 153112 shares were traded.

Ratios:

Our goal is to gain a better understanding of LENZ by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 39.20 and its Current Ratio is at 39.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on March 27, 2024, initiated with a Overweight rating and assigned the stock a target price of $28.

Cantor Fitzgerald Downgraded its Overweight to Neutral on February 23, 2023, while the target price for the stock was maintained at $3.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 21 ’24 when RA CAPITAL MANAGEMENT, L.P. bought 998,009 shares for $15.03 per share. The transaction valued at 15,000,075 led to the insider holds 3,319,339 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LENZ now has a Market Capitalization of 559.82M and an Enterprise Value of 472.03M.

Stock Price History:

Over the past 52 weeks, LENZ has reached a high of $23.50, while it has fallen to a 52-week low of $9.91. The 50-Day Moving Average of the stock is 4.23, while the 200-Day Moving Average is calculated to be 2.91.

Shares Statistics:

The stock has traded on average 61.74K shares per day over the past 3-months and 399.76k shares per day over the last 10 days, according to various share statistics. A total of 8.29M shares are outstanding, with a floating share count of 3.94M. Insiders hold about 52.59% of the company’s shares, while institutions hold 63.01% stake in the company.

Earnings Estimates

Its stock is currently analyzed by 1 different market analysts. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.11 and a low estimate of -$0.11, while EPS last year was -$3.01. The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.

Analysts are recommending an EPS of between -$0.4 and -$0.4 for the fiscal current year, implying an average EPS of -$0.4. EPS for the following year is -$0.4, with 1 analysts recommending between -$0.4 and -$0.4.

Most Popular